We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
The Mission Marketing Group Plc | LSE:TMMG | London | Ordinary Share | GB00B11FD453 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 78.50 | 77.00 | 80.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/1/2018 09:16 | GHF, thanks. Can't really argue with that! I've been in here for what feels like an eternity and have never sold a share. In fact every time we have the rise then inevitable fall I add at circa 40-41p. This is now a disproportionately high percentage of my portfolio (I'm sure peanuts in monetary terms compared to most, but significant to me) and it will remain that way whist the statements and results continue as they have for the last few years. GLA | red_shed2000 | |
10/1/2018 08:57 | TMMG Like many investors I’ve reviewed my holdings & watchlist during the last fortnight. I topped up and added substantially in relation to a few (such as CROS, OPM & PTY) which appeared undervalued - IMHO - in relation to prospects. Another on my list was an old favourite, The Mission Marketing (TMMG), a marketing communications & advertising company. This company has been in & out of my portfolio during the last few years. Last invested here in early 2016. TMMG’s profitability had recovered during recent years after running into difficulties & ramp up of debt suffered in the wake of the 2008/09 financial crisis. The FY09 results highlighted that net debt had ballooned to £20m & David Morgan was parachuted in as CEO as debt was restructured. Since 2014 the shares have been rangebound between 35p-50p with few exceptions. They are currently 43p mid-price having yet again failed to break the 50p ceiling. They have been on a high single digit PER for as long as I can remember. I feel that this may be about to change. “Why now?”... I here you ask. Well, the market have given this company a wide berth over the last few years. However - you knew there was to be a further however - their performance over the last 7 years belies this weak share price IMHO. They have delivered consistent earnings growth over the period, with exception of 2013 (nil growth) while introducing a progressive dividend policy in 2013. Earnings Record - year end Dec 2010A EPS 3.5p 2011A EPS 4.2p (+22% EPS growth) 2012A EPS 4.5p (+7% EPS growth) 2013A EPS 4.5p (nil growth) / Div 1p 2014A EPS 5.1p (+15% EPS growth) / Div 1.1p 2015A EPS 5.9p (+15% EPS growth) / Div 1.2p 2016A EPS 6.4p (+9% EPS growth) / Div 1.5p Forecasts 2017E EPS 7p (+11% EPS growth) / est. Div 1.7p (yield 4%) 2018E EPS 7.8p (+12% EPS growth) / est. Div 1.8p (yield 4.2%) 2019E EPS 8.8p (+13% EPS growth) / est. Div 2.0p (yield 4.7%) A credible record due in part to the long term relationships they have established with an exceptional blue chip client base. Presentation link below highlights (on p6) the fact that Aviva, BP & Bellway have been clients for over 20 years! Recent client wins, per their interim statement, include Mars, Neff, Reckitt Benckiser, Revlon, The Royal Mint and Universal Studios. As mentioned this strong client retention means they have better revenue visibility than many peers with 57% of their revenues delivered from clients of 5 years standing or more. The company have also grown to encompass 14 agencies across the globe. TMMG have quietly flown under the radar despite forecasts of double digit CAGR during the next 3 years. They also introduced a dividend in 2013, and as observed, the yield is forecast to have crept up to 4% for 2017. Meanwhile, net debt has reduced from £20m in 2018 to £11m today. Should be noted that once net debt reduced to c.£10m they undertook a few small bolt on acquisitions over the last couple of years. Importantly, free cashflow & margins are also expected to improve during the next few years. In 2016 FCF was £4.5m for a yield of 13.3% and in 2017 forecast to be £4.2m for yield of 12.3%. With investment made in recent years its is forecast to substantially improve in 2018 & 2019 to 17.6% & 19.5% respectively. PBT margins are also forecast to increase from 10.7% in 2016 to 12.6% in 2019. It should be noted that the company have a large H2 weighting - as anyone who reviews their interim statements will have observed over the years. This may be one reason for the low rating, as we all know that statement implying a H2 weighting may be perceived as a pending profit warning in many cases. Interim presentation here So, in summary, the share price has gone nowhere for the last 3 years, while earnings have returned low double digit growth. I believe that if TMMG continue to deliver as per forecast, then it would not surprise me to see them break out from 35p-50p range before too long. Is it speculative to consider that they could double from the current share price price (43p) over the course of the next 18/24 months???... and while one is waiting there is a 4% dividend yield on offer that rises to 4.7% by 2019. Even if the share price doubled, on 7.8p forecast earnings in 2018 & 8.8p EPS in 2019, they would only be on a PER 10 - 11, which is hardly a racy multiple. Stock - o - pedia appear to agree, with TMMG on a Stock Rank rating of 91 & Magic Formula score A+ Disclosure I’ve been buying over recent sessions so as always, please consider my musings with a large pinch of salt and DYOR. This is not a full write-up but simply a short synopsis. Kind regards, GHF | glasshalfull | |
06/12/2017 11:19 | Don't agree about the director selling. Of more interest is the institutional buying that went with it, a big positive. Share price imo at stale bulls point, price driven down on no news and very little volume and an excellent long term buying opportunity. | bbluesky | |
05/12/2017 20:24 | I sold 30% at 42. Hopefully I’ll come to regret that, but the director sell was right at the peak. That still has a lot of influence on the current share price IMO. | dr biotech | |
05/12/2017 10:43 | Well against my better judgement I have topped up today. I am so over weight here it's untrue but I really don't understand why the share price hasn't moved for 3 years despite ever increasing profits and cash flow. One day they will either fly or be taken over. I just repeat the same phrase here month after month - the market can remain irrational longer than I can remain rational.... | red_shed2000 | |
16/11/2017 17:12 | Back to the standard trading range... | dr biotech | |
03/11/2017 14:28 | Satchhi moving up, should tow TMMG along. I would say there is at least a 2:1 valuation gap compared with SAA, meaning this should double. A great underappreciated quality company going cheap. | kmann | |
31/10/2017 15:31 | Holdings increase. Is this up for a takeout? Looks cheap, always has compared to Satchi. Should be double this share price I think the new Nomad has already help lift the investor profile enough. Should really move now the insti's have loaded up or get taken out. BUY £1 MINIMUM | kmann | |
25/10/2017 10:08 | Think it was a sell, with the trade reported late. | dr biotech | |
24/10/2017 17:09 | huge buy today of 440,000 shares (£198,000). | mfhmfh | |
24/10/2017 13:35 | Seems that the "institutional demand" was short lived. Shame he didn't wait a bit longer, we are back to the normal trading range. | dr biotech | |
20/10/2017 17:19 | Hmmm. They could have issued new shares and paid down debt if demand had been that high. Of course directors have a right to sell, but it seems he sold at first chance above 50p | dr biotech | |
20/10/2017 16:36 | director sell was 'in order to satisfy institutional demand' according to RNS. he also sold and then re-bought 323,000 shares for his pension fund. I'm sure BGF Investment Management Limited have gone over 3m shares as they see the share price moving significantly higher. IMHO. | mfhmfh | |
20/10/2017 15:23 | That director sell has caused a lot of damage. Confidence has always been a bit fragile with these. | dr biotech | |
17/10/2017 08:12 | BGF Investment Management Limited have moved above 3%. link to the website below: hxxps://www.bgf.co.u 'BGF is the UK and Ireland’s most active investor in growing businesses' | mfhmfh | |
16/10/2017 14:54 | interesting director sale due to institutional demand: 'The Mission Marketing Group plc ("TMMG" or "the missiontm"), the marketing communications and advertising group, was notified by Robert Day, an Executive Director of the Company, on 13 October 2017 that, in order to satisfy institutional demand, he sold 1,000,000 ordinary shares of 10p each in the capital of the Company ("Ordinary Shares") at a price of 48 pence per Ordinary Share on 13 October 2017.' | mfhmfh | |
13/10/2017 13:12 | Anyone think this could be a TO target or is this reacting to the new bus win belatedly do you think? | qs99 | |
13/10/2017 13:02 | boom there you go! | qs99 | |
13/10/2017 12:54 | decent reversal today, looks like they want your stock IMO. Have tried buying a k or over and not getting any joy on quote and deal....DYOR but looks good for a decent rise IMO... | qs99 | |
13/10/2017 11:59 | TMMG at 48p – the contract win for DTI is , I think, hugely significant. TMMG share price has been lowly rated for years not for the lack of profit growth, cash generating, debt reduction, or dividend increases! But because of worries re being a people business, the general quality for a small cap plc, the quality of earnings when CASH is regularly used to buy in growth. I think this contract puts these all to bed , and some…. As a multi year contract, across multiple countries, which is of the highest profile (BREXIT for world’s 7th biggest economy!), it means that people will stay with the agency for the experience, it is organic growth rather than an acquisition, it is highly visible and its gives the company huge credibility. So I think it bats away investors previous concerns. What are the financials... well no update from the company yet but it is easy to play around with averages for conferences and get £1m to £2m per year – probably at the lower end of this range. Remember the agency Bray Leino, which has a 20 year growth record, which is c. 40% of TMMG t/o has said it is the most significant thing in their history! So it seems reasonable to assume it is significant. Much more so, I think it wil enable TMMG to pitch and convert to sales much more easily so their will be a significant halo affect. Other aspects… in the last 3 RNS’s TMMG has enthused about all the other agencies and their progress and opportunities – there is little mention of Bray Leino – so this is on top of current expectations. When TMMG announced their ‘growth scheme’ in March the CEO of Bray Leino got the highest level of incentive shares. I thought that was interesting because the salary of all the board members is pretty much the same some take it as salary, others as benefits but , aside from founder David Morgan, they are pretty much banded. – which is intentional to ensure equality amongst these different entrepeneurs. My view is that TMMG felt this contract was a possibility way back at the start of the year and created a ‘growth scheme’ which gave them reward if it was pulled off. At the time the share price hurdle of 75p seems ludicrous compared to the market price of 40p but I think now it gives an indication as to what potential they see in future contracts. And of course we don’t know what else they have yet to announce.. the latest RNS was stuffed full of optimism for future pitches. And the chart…. There is a classic flag break, with volume, out of a growth trend going back to 2010 which predicts a price move to c.80p which was previous resistance. From this break out there is no resistance until that point though I think 50p will be a sticking point for some technical analysis. The catalyst for a major move would be an RNS from the company. Paul Scott owns the shares so I think any positive RNS will be highlighted through him and also ST is likely to update positively. All IMHO, DYOR + BoL TMMG is in my top 5 hldgs | thirty fifty twenty | |
13/10/2017 07:05 | wonder whether we will breach 50p today?! | qs99 | |
12/10/2017 15:49 | Hope the share price can finally break 50p | mfhmfh | |
12/10/2017 14:53 | well heading towards 50p it would seem GLA | qs99 | |
12/10/2017 14:51 | I wonder who won lot 1 and what it was. | cliffpeat | |
12/10/2017 12:18 | well even on my figures it is less than 10% of profits so no tech need to release. I think this puts them at the forefront of BREXIT which is huge credibility for a business that is valued at £40m!! it secures CASH flow and follow on work from clients must be very likely in time as is a higher rating by investors. All IMH, DYOR + BoL TMMG is in my top5 hldgs | thirty fifty twenty |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions